Compositions for affecting weight loss

Details for Australian Patent Application No. 2006275914 (hide)

Owner Orexigen Therapeutics, Inc.

Inventors Higgin, Michelle S; Mccall, John M; Mckinney, Anthony A; Tollefson, Gary

Agent Cullen & Co

Pub. Number AU-A-2006275914

PCT Pub. Number WO2007/016108

Priority 60/702,877 27.07.05 US

Filing date 24 July 2006

Wipo publication date 8 February 2007

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/016108 Priority application(s): WO2007/016108

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006275918-Use of adipose tissue-derived stromal cells in spinal fusion

2006275907-Method and system for configuring and data populating a surgical device